To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Hi Jill
I posted a question to you on Twitter / X, hoping I could use the 2 slides you prepared that Ben Solomon (a work colleague of mine) used at the ASCO AM this year
Thanks for letting me know
Michael
Dear Ms. Feldman,
I’m a producer working with SBS-TV, one of the top three broadcasting networks, in South Korea. We would love to interview you for a documentary about a new therapy involving Lazcluze you commented in “ FDA Approves Johnson & Johnson’s Rybrevant and Lazcluze for Advanced Non-Small Cell Lung Cancer.”
Have you been treated with this new therapy? Do you know patients who have benefited from the MARIPOSA trial?
Look forward to your reply. We would like to interview you early next week. You can call me at 347-330-0290 to discuss further. Many thanks. Sabina